Kelkheim, Germany

Karlheinz Budt

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karlheinz Budt. Retrieved from https://idiyas.com/inventor/karlheinz-budt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karlheinz Budt

Introduction

Karlheinz Budt is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases caused by DNA and RNA viruses. His innovative approach has led to the development of a unique compound that holds promise for medical applications.

Latest Patents

Karlheinz Budt holds a patent for the "Use of benzylphosphonic acid derivatives for the treatment of diseases." This patent describes the use of a compound with a specific formula that includes various alkyl groups and other chemical components. The invention aims to provide a therapeutic solution for diseases caused by viral infections, showcasing Budt's commitment to advancing medical science.

Career Highlights

Budt is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on innovative research and development, contributing to the company's reputation for excellence in medical advancements.

Collaborations

Throughout his career, Karlheinz Budt has collaborated with esteemed colleagues such as Jochen Knolle and Matthias Helsberg. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Karlheinz Budt's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to inspire future advancements in the treatment of viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…